Iovance

Developer of T-cell therapies for the treatment of cancer

placeSan Carlos, California, United States calendar_todayFounded 2007 groups557 employees language iovance.com

Registered entities

Social engagement

Social engagement: 38.6K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital350%
Private equity350%

Recent activity

5 Jun 2026
Milestone
regulatory
4 Jun 2026
Event
2026 Jefferies Global Healthcare Conference
1 Jun 2026
Product launch
IL-12 Tethered TIL Therapy IOV-5001
Coming soon